Suppr超能文献

组织因子途径抑制物、抗凝血酶III和肝素辅因子II等化学计量抑制剂对组织因子启动的凝血酶生成的调节作用。

Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.

作者信息

van 't Veer C, Mann K G

机构信息

Department of Biochemistry, University of Vermont, Burlington, Vermont 05405-0068, USA.

出版信息

J Biol Chem. 1997 Feb 14;272(7):4367-77. doi: 10.1074/jbc.272.7.4367.

Abstract

The effects of the stoichiometric inhibitors tissue factor pathway inhibitor (TFPI), antithrombin-III (AT-III) and heparin cofactor-II (HC-II) on thrombin generation were evaluated in a reaction system composed of coagulation factors VIIa, X, IX, VIII, and V and prothrombin initiated by tissue factor (TF) and phospholipids. Initiation of the reaction in the absence of inhibitors resulted in explosive thrombin generation for factor VIIa.TF concentrations varying from 100 to 0.25 pM with the lag time or initiation phase of thrombin generation increasing from 0 to 180 s with decreasing factor VIIa.TF concentrations. During the propagation phase, prothrombin is quantitatively activated to 1.4 micro;M alpha-thrombin. At normal plasma concentration (2.5 nM) full-length recombinant TFPI prolonged the initiation phase of thrombin generation 2-fold, and the rate of thrombin generation in the propagation phase of the reaction was 25-50% that of the uninhibited reaction when the reaction was initiated with 1.25-20 pM factor VIIa.TF. Inhibition of the reaction by TFPI is associated with a delay in factor V activation. In the presence of TFPI no explosive thrombin generation was observed when factor VIII was omitted from reactions initiated by factor VIIa.TF concentrations </=20 pM. This indicates that in the presence of TFPI the factor IXa.factor VIIIa pathway becomes essential at low factor VIIa.TF concentrations. In the reconstituted system, AT-III (3.4 micro;M) did not prolong the initiation phase of thrombin generation when the reaction was initiated with 1.25 pM factor VIIa.TF, nor did AT-III delay factor V activation. The rate of thrombin formation in the presence of AT-III was reduced to 30% that of the uninhibited reaction, and the alpha-thrombin formed was rapidly inhibited subsequent to its generation. The addition of HC-II alone at its physiological concentration (1.38 micro;M) to the procoagulant mixture did not alter the rate or extent of thrombin generation. Subsequently, the thrombin formed was slowly inhibited by HC-II. The slow inactivation of thrombin by HC-II does not contribute to thrombin inhibition in the presence of AT-III. In contrast, the combination of physiological levels of AT-III and TFPI inhibited explosive thrombin generation initiated by 1.25 pM factor VIIa.TF completely. The absence of prothrombin consumption indicated that the combination of TFPI and AT-III is able to prevent the formation of prothrombinase activity at low factor VIIa.TF concentrations. The data indicate that TFPI potentiates the action of AT-III by decreasing the rate of formation and thus the amount of catalyst formed in the reaction, enabling AT-III to effectively scavenge the limited traces of factor IXa and factor Xa formed in the presence of TFPI. The initiation of thrombin generation by increasing factor VIIa.TF concentrations in the presence of physiological concentrations of TFPI and AT-III showed dramatic changes in the maximal rates of thrombin generation over small changes in initiator concentration. These data demonstrate that significant thrombin generation becomes a "threshold-limited" event with regard to the initiating factor VIIa.TF concentration in the presence of TFPI and AT-III.

摘要

在由凝血因子VIIa、X、IX、VIII和V以及凝血酶原组成的反应体系中,通过组织因子(TF)和磷脂引发反应,评估了化学计量抑制剂组织因子途径抑制剂(TFPI)、抗凝血酶III(AT-III)和肝素辅因子II(HC-II)对凝血酶生成的影响。在不存在抑制剂的情况下引发反应会导致因子VIIa引发爆炸性凝血酶生成。TF浓度从100 pM变化到0.25 pM时,随着因子VIIa.TF浓度降低,凝血酶生成的滞后时间或起始阶段从0增加到180秒。在传播阶段,凝血酶原被定量激活至1.4 μM的α-凝血酶。在正常血浆浓度(2.5 nM)下,全长重组TFPI将凝血酶生成的起始阶段延长了2倍,当用1.25 - 20 pM因子VIIa.TF引发反应时,反应传播阶段的凝血酶生成速率是未抑制反应的25 - 50%。TFPI对反应的抑制与因子V激活延迟有关。当因子VIII从由因子VIIa.TF浓度≤20 pM引发的反应中省略时,在存在TFPI的情况下未观察到爆炸性凝血酶生成。这表明在存在TFPI的情况下,在低因子VIIa.TF浓度时因子IXa.因子VIIIa途径变得至关重要。在重构体系中,当用1.25 pM因子VIIa.TF引发反应时,3.4 μM的AT-III没有延长凝血酶生成的起始阶段,也没有延迟因子V激活。存在AT-III时的凝血酶形成速率降低至未抑制反应的30%,并且生成的α-凝血酶在生成后迅速被抑制。将生理浓度(1.38 μM)的HC-II单独添加到促凝混合物中不会改变凝血酶生成的速率或程度。随后,形成的凝血酶被HC-II缓慢抑制。在存在AT-III的情况下,HC-II对凝血酶的缓慢失活无助于凝血酶抑制。相反,生理水平的AT-III和TFPI的组合完全抑制了由1.25 pM因子VIIa.TF引发的爆炸性凝血酶生成。凝血酶原消耗的缺乏表明TFPI和AT-III的组合能够在低因子VIIa.TF浓度下防止凝血酶原酶活性的形成。数据表明,TFPI通过降低形成速率从而减少反应中形成的催化剂数量来增强AT-III的作用,使AT-III能够有效清除在存在TFPI时形成的有限痕量因子IXa和因子Xa。在存在生理浓度的TFPI和AT-III的情况下,通过增加因子VIIa.TF浓度引发凝血酶生成显示,在引发剂浓度的微小变化范围内,凝血酶生成的最大速率发生了显著变化。这些数据表明,在存在TFPI和AT-III的情况下,就起始因子VIIa.TF浓度而言,显著的凝血酶生成成为一个“阈值限制”事件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验